Overview
Description
Argent Biopharma Ltd. is a leading company in the biotechnology sector, focusing on the development and commercialization of innovative therapeutic solutions. The primary function of the company is to address unmet medical needs through cutting-edge research in areas such as oncology, rare diseases, and chronic conditions. Argent Biopharma Ltd. is known for its commitment to advancing scientific research and bringing groundbreaking therapies from laboratory to market.
The biotechnology firm actively collaborates with academic institutions and research organizations, leveraging partnerships to enhance its pipeline of drug candidates. Additionally, Argent Biopharma Ltd. invests heavily in research and development, with a substantial portion of its resources dedicated to clinical trials and regulatory processes.
In the financial market, Argent Biopharma Ltd. plays a crucial role as an innovator in the healthcare industry, contributing to the advancement of medical science and therapeutic options. Its efforts not only impact patient care but also influence trends and developments within the broader biopharmaceutical landscape. The company's presence signifies a strong commitment to improving patient outcomes and healthcare advancements.
About
CEO
Ms. Sasha Friedman
Employees
0
Address
295 Rokeby Road
Suite 1
Subiaco, 6008, WA
Australia
Suite 1
Subiaco, 6008, WA
Australia
Phone
61 8 6555 2950
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Australia
MIC code
XASX